We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

36 hedge funds and large institutions have $10.4M invested in Histogen Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 4

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

74% more call options, than puts

Call options by funds: $200K | Put options by funds: $115K

13% more funds holding

Funds holding: 3236 (+4)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1% less capital invested

Capital invested by funds: $10.5M → $10.4M (-$132K)

Holders
36
Holders Change
+4
Holders Change %
+12.5%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
7
Increased
11
Reduced
4
Closed
3
Calls
$200K
Puts
$115K
Net Calls
+$85K
Net Calls Change
+$120K

HSTO Hedge Fund Activity: Q2 2016 in Review

36 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2016, worth a combined $10.4M — down 1.3% from $10.5M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new HSTO positions and 3 closed out — a net gain of 4 holders — while 11 added to existing stakes and 4 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $71.5K. The largest seller was Bridgeway Capital Management, cutting an estimated $159K.

  • 36 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2016, up from 32 in Q1 2016.
  • Funds reported $10.4M of Histogen Inc. Common Stock stock for Q2 2016, down 1.3% quarter-over-quarter.
  • 7 funds opened new Histogen Inc. Common Stock positions in Q2 2016 and 3 closed out, a net change of +4 holders.
  • The largest Histogen Inc. Common Stock buyer in Q2 2016 was D.E. Shaw & Co, an estimated $71.5K added.
  • The largest Histogen Inc. Common Stock seller in Q2 2016 was Bridgeway Capital Management, an estimated $159K sold.

Based on aggregated 13F filings for Q2 2016.